Stampfer Martha R, Garbe James, Nijjar Tarlochan, Wigington Don, Swisshelm Karen, Yaswen Paul
Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA 94720, USA.
Oncogene. 2003 Aug 14;22(34):5238-51. doi: 10.1038/sj.onc.1206667.
We describe novel effects of p53 loss on immortal transformation, based upon comparison of immortally transformed human mammary epithelial cell (HMEC) lines lacking functional p53 with closely related p53(+) lines. Our previous studies of p53(+) immortal HMEC lines indicated that overcoming the stringent replicative senescence step associated with critically short telomeres (agonescence), produced indefinite lifespan lines that maintained growth without immediately expressing telomerase activity. These telomerase(-) 'conditionally immortal' HMEC underwent an additional step, termed conversion, to become fully immortal telomerase(+) lines with uniform good growth. The very gradual conversion process was associated with slow heterogeneous growth and high expression of the cyclin-dependent kinase inhibitor p57(Kip2). We now show that p53 suppresses telomerase activity and is necessary for the p57 expression in early passage p53(+) conditionally immortal HMEC lines, and that p53(-/-) lines exhibit telomerase reactivation and attain full immortality much more rapidly. A p53-inhibiting genetic suppressor element introduced into early passages of a conditionally immortal telomerase(-) p53(+) HMEC line led to rapid induction of hTERT mRNA, expression of telomerase activity, loss of p57 expression, and quick attainment of uniform good growth. These studies indicate that derangements in p53 function may impact malignant progression through direct effects on the conversion process, a potentially rate-limiting step in HMEC acquisition of uniform unlimited growth potential. These studies also provide evidence that the function of p53 in suppression of telomerase activity is separable from its cell cycle checkpoint function.
我们通过比较缺乏功能性p53的永生化人乳腺上皮细胞(HMEC)系与密切相关的p53(+)系,描述了p53缺失对永生化转化的新影响。我们之前对p53(+)永生化HMEC系的研究表明,克服与临界短端粒相关的严格复制性衰老步骤(衰老),产生了寿命无限的细胞系,这些细胞系在不立即表达端粒酶活性的情况下维持生长。这些端粒酶(-)“条件性永生化”HMEC经历了另一个步骤,称为转化,以成为具有均匀良好生长的完全永生化端粒酶(+)系。非常缓慢的转化过程与缓慢的异质性生长和细胞周期蛋白依赖性激酶抑制剂p57(Kip2)的高表达有关。我们现在表明,p53抑制端粒酶活性,并且对于早期传代的p53(+)条件性永生化HMEC系中p57的表达是必需的,并且p53(-/-)系表现出端粒酶重新激活并更快地获得完全永生化。将p53抑制性遗传抑制元件引入条件性永生化端粒酶(-) p53(+) HMEC系的早期传代中,导致hTERT mRNA的快速诱导、端粒酶活性的表达、p57表达的丧失以及快速获得均匀良好的生长。这些研究表明,p53功能的紊乱可能通过对转化过程的直接影响来影响恶性进展,转化过程是HMEC获得均匀无限生长潜力的潜在限速步骤。这些研究还提供了证据,表明p53在抑制端粒酶活性方面的功能与其细胞周期检查点功能是可分离的。